The approach is to block a special receptor that is responsible for balancing the consumption of food consumed.
In Australia, biologists at the Garvan Institute of Medical Research have discovered another way to combat obesity.
Scientists have discovered that blocking a specific receptor in adipose tissue affects the metabolic process, which contributes to the expenditure of fat for energy and thermoregulation of the human body.
- Does Covid-19 change DNA? This is what virologist says about the new study
- This is how serious blood clots trigger in a coronavirus patient
- Three hot beverages that reduce the risk of cancer and heart diseases named
- A new method of protection against COVID revealed
- A man chases his stolen Lamborghini on a ‘scooter’
Obesity is noted to be caused by an imbalance between food calories and energy expenditure. And drugs to combat obesity are aimed only at reducing appetite.
Researchers have developed a new approach in which the drug works exclusively on adipose tissue.
“The Y1 receptor acts as a “brake” of heat generation in the body. Blocking this receptor in fat tissues turns “energy-saving” fat into fat, which is used to generate energy and heat,” the release says.
It blocks the receptor for the neuropeptide Y1 (NPY) molecule, which is activated in the presence of food shortages and promotes energy conservation.
In addition, this receptor can improve fat processing and reduce the risk of weight gain.
The results of the study appeared in the journal Nature Communications.
Image Credit: Getty